AdenocarcinomaAntineoplastic Combined Chemotherapy ProtocolsCapecitabine
Dr. Matthew Curtis Solhjem, MD
NPI1356334403PAC ID1759295421
- Medicare services, 2024
- 984
- Medicare patients, 2024
- 180
- Part D claims, 2024
- 307
- Publications
- 3
- Clinical trials
- 9
- Practice address
- 4805 NE Glisan Street, Portland, OR 97213
- Practice phone
- Call (503) 215-1111
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Solhjem's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Matthew Curtis Solhjem is a radiation oncologist in Portland, Oregon
Dr. Solhjem practices at Providence Portland Medical Center in Portland, Oregon, part of Providence Health & Services.
Dr. Solhjem's NPI, 1356334403, was assigned on August 24, 2005. Dr. Solhjem graduated from University of Minnesota Medical School in 2000. Dr. Solhjem holds Oregon license MD25755.
NPI and contact details
- NPI
- 1356334403NPI Registry (opens in a new tab)
- Medicare PAC ID
- 1759295421
- NPI enumeration date
- August 24, 2005
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (503) 215-1111
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 52
- Medical school graduation
- 2000
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Matthew Curtis Solhjem practices at Providence Portland Medical Center in Portland, Oregon
Dr. Solhjem's primary practice is Providence Portland Medical Center, at 4805 NE Glisan Street, Portland, OR 97213 in Multnomah County. The practice phone is (503) 215-1111.
- Providence Portland Medical Center4805 NE Glisan Street, Portland, OR 97213 · Multnomah CountyPhone(503) 215-1111
Source: Dmand AI Affiliation Data
Dr. Matthew Curtis Solhjem is affiliated with 2 sites of care and 1 medical group
Dr. Solhjem's primary practice is Providence Portland Medical Center in Portland, Oregon, part of Providence Health & Services. Dr. Solhjem is also affiliated with Providence St. Vincent Medical Center. The medical group on file is The Oregon Clinic.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Matthew Curtis Solhjem's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Solhjem practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Providence Portland Medical Center | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Solhjem practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Providence Health & Services and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Matthew Curtis Solhjem is one of 98 radiation oncologists in Oregon
Radiation oncology is Dr. Solhjem's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Solhjem is licensed in Oregon.
Specialties and state licenses
- Radiation oncology, OregonPrimary
Radiation oncologists near Dr. Solhjem
Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.
98radiation oncologists in Oregon47radiation oncologists in Portland7radiation oncologists at Providence Portland Medical Center
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Matthew Curtis Solhjem billed Medicare for 984 services in 2024
CMS data shows 984 Medicare services from Dr. Solhjem across 15 procedure codes in 2024, for 180 Medicare patients. Medicare paid $84,652 for them. Every service was in a facility, such as a hospital, rather than an office.
Medicare services, 2024984
Medicare patients180
Paid by Medicare$84,652
Procedure codes15
Dr. Solhjem's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Imaging
- 2023: 6702024: 91036%
- Office and hospital visits
- 2023: 462024: 7461%
Dr. Solhjem compared with the Oregon median for radiation oncologists, 2024
- Dr. Solhjem
- Oregon median
- Medicare services
- 984vs 83917% above
- Medicare patients
- 180vs 14029% above
- Part D claims
- 246vs 475.2 times
Medians across 99 radiation oncologists in Oregon with Dmand AI profiles that report each measure.
Dr. Solhjem's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Solhjem?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Solhjem and other radiation oncologists in Oregon.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Matthew Curtis Solhjem treated 180 Medicare patients in 2024, average age 74
CMS counts 180 Medicare patients who saw Dr. Solhjem in 2024. The largest group is 65 to 74, with 92 patients. 75% of them have cancer, and 69% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.48, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Solhjem's median patient age at 74, with 18% women.
Medicare patients, 2024180
Average age74
Average risk score1.48
Also on Medicaid14%
Dr. Solhjem's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Solhjem's Medicare patients by sex, 2024
- Women6033%
- Men12067%
Chronic conditions among Dr. Solhjem's Medicare patients, 2024
- Cancer75%
- High blood pressure69%
- High cholesterol63%
- Arthritis34%
- Chronic kidney disease29%
- Diabetes24%
- Mood disorders24%
- Depression23%
Share of Medicare patients with each condition. A patient can have several.
Dr. Solhjem's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 74
Patient panel by sex, all payers
- Women18%
- Men81%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Matthew Curtis Solhjem wrote 307 Medicare Part D claims in 2024
In 2024, Dr. Solhjem wrote 307 Medicare Part D claims for 113 patients. 99% of them were for generic drugs. CMS names the drug for 246 of them, across 7 drugs with 11 or more claims each, at $2,913 in total drug cost. In 2023, CMS named 94 claims across 3 drugs.
Part D claims, 2024307
Drugs named by CMS7
Total drug cost$2,913
Part D patients113
Dr. Solhjem's Part D claims by kind of drug, 2024
- Generic304 claims99%
- Brand-name and other3 claims1%
Dr. Solhjem's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Solhjem's Part D claims, 2024
- Opioids13%39 of 307 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 942024: 246162%
Drugs named by CMS: 7 in 2024, 3 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Matthew Curtis Solhjem offers telehealth to Medicare patients
Dr. Solhjem accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Solhjem as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Find radiation oncologists like Dr. Solhjem by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Matthew Curtis Solhjem has 3 publications on record
Dmand AI links 3 papers to Dr. Solhjem, published from 2016 to 2022. 2016 was the busiest year, with 2. Dr. Solhjem's most frequent co-authors are Marka Rae Crittenden, MD, PhD, Kristina Hoot Young, MD, PhD and Rehan Saeed Ahmad, MD.
Papers3
Years published2016 to 2022
Dr. Solhjem's most frequent co-authors
- Marka Rae Crittenden, MD, PhD2 shared papers
- Kristina Hoot Young, MD, PhD2 shared papers
- Rehan Saeed Ahmad, MD1 shared paper
Recent publications by Dr. Solhjem
See who Dr. Solhjem researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Solhjem works with, so you can find a warm path to the right radiation oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Matthew Curtis Solhjem has worked on 9 clinical trials
Dmand AI links Dr. Solhjem to 9 clinical trials, 4 of them phase 2 studies. 5 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell and Glioblastoma. Providence Health & Services sponsors the most, 6.
Clinical trials with Dr. Solhjem by phase
- 2Phase 1: 2 trials
- 1Phase 1/2: 1 trial
- 4Phase 2: 4 trials
- 2Phase 3: 2 trials
- NonePhase 4: no trials
Conditions in Dr. Solhjem's trials
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Glioblastoma
- Melanoma
- Neoplasm Metastasis
Investigators on the most trials with Dr. Solhjem
- Alice Wang-Chesebro, MD6 shared trials
- Marka Rae Crittenden, MD, PhD5 shared trials
- Steven Kysung Seung, MD, PhD5 shared trials
Recent clinical trials with Dr. Solhjem
Phase II Randomized Study of High Dose Interleukin-2 Versus Stereotactic Body Radiation (SBRT) and High Dose Interleukin-2 (IL-2) in Patients With Metastatic Melanoma (opens in a new tab)
Active, not recruitingPhase 2
MelanomaNevi and MelanomasHigh-dose IL-2
Phase II Study of TGFβ Type I Receptor Inhibitor LY2157299 With Neoadjuvant Chemoradiation in Patients With Locally Advanced Rectal Adenocarcinoma (opens in a new tab)
Active, not recruitingPhase 2
Rectal NeoplasmsRectal DiseasesLY2157299CapecitabineFluorouracil
Phase II Randomized Study of High Dose Interleukin-2 Versus Stereotactic Body Radiation (SBRT) and High Dose Interleukin-2 (IL-2) in Patients With Metastatic Renal Cancer (opens in a new tab)
Active, not recruitingPhase 2
Carcinoma, Renal CellKidney NeoplasmsSBRTHigh Dose IL-2
Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (opens in a new tab)
Active, not recruitingPhase 1/2
Squamous Cell Carcinoma of Head and NeckCarcinoma, Squamous CellNivolumabRadiation (3 days)Radiation (5 days)
GlioblastomaAstrocytomaAntibioticsCohort 1Cohort 2
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Matthew Curtis Solhjem received $2,429 in industry payments from 2017 to 2025
CMS Open Payments shows 25 general payments to Dr. Solhjem from 9 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 73% of the total. Teleflex LLC paid the most, $1,110.
General payments to Dr. Solhjem by program year, 2017 to 2025
General payments to Dr. Solhjem by kind, 2017 to 2025
$2.4Kin total
- Food and beverage$1,78073%
- Travel and lodging$64927%
Companies that paid Dr. Solhjem the most, 2017 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Matthew Curtis Solhjem graduated from University of Minnesota Medical School
Dr. Solhjem graduated from University of Minnesota Medical School in 2000.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Matthew Curtis Solhjem's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Matthew Curtis Solhjem
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Matthew Curtis Solhjem's NPI number?
Dr. Matthew Curtis Solhjem's NPI number is 1356334403. It was assigned on August 24, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Matthew Curtis Solhjem?
Dr. Matthew Curtis Solhjem is a radiation oncologist in Portland, Oregon. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).
Where does Dr. Matthew Curtis Solhjem practice?
Dr. Solhjem practices at 4805 NE Glisan Street, Portland, OR 97213. Dr. Solhjem's primary practice is Providence Portland Medical Center in Portland, Oregon, part of Providence Health & Services.
What is Dr. Matthew Curtis Solhjem's office phone number?
The practice phone on file for Dr. Solhjem is (503) 215-1111.
What is Dr. Matthew Curtis Solhjem's medical license number?
Dr. Solhjem holds Oregon license MD25755.
Which hospitals is Dr. Matthew Curtis Solhjem affiliated with?
Dr. Solhjem practices at Providence Portland Medical Center in Portland, Oregon. Dr. Solhjem is also affiliated with Providence St. Vincent Medical Center.
What medical group is Dr. Matthew Curtis Solhjem part of?
Dr. Solhjem is linked to The Oregon Clinic.
Does Dr. Matthew Curtis Solhjem accept Medicare?
Yes. CMS data shows Dr. Solhjem billed Medicare for 984 services in 2024, and Dr. Solhjem accepts Medicare assignment.
Does Dr. Matthew Curtis Solhjem offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Solhjem as offering telehealth services.
How many Medicare patients does Dr. Matthew Curtis Solhjem see?
CMS counts 180 Medicare patients who saw Dr. Solhjem in 2024, with an average age of 74.
Show 7 more questionsShow fewer questions
What services does Dr. Matthew Curtis Solhjem bill to Medicare?
In 2024, Dr. Solhjem's most billed Medicare services were radiation oncology (77014), radiation oncology (77300) and radiation oncology (77427).
Where did Dr. Matthew Curtis Solhjem go to medical school?
Dr. Solhjem graduated from University of Minnesota Medical School in 2000.
What drugs does Dr. Matthew Curtis Solhjem prescribe most?
In 2024 Medicare Part D data, Dr. Solhjem's most prescribed drugs by claims were Tamsulosin HCl, Hydrocodone-Acetaminophen and Oxybutynin Chloride ER.
Has Dr. Matthew Curtis Solhjem received payments from drug or device companies?
CMS Open Payments shows $2,429 in general payments to Dr. Solhjem from 9 companies from 2017 to 2025. The largest total came from Teleflex LLC.
How long has Dr. Matthew Curtis Solhjem been practicing?
Dr. Solhjem graduated from medical school in 2000, 26 years ago.
Does Dr. Matthew Curtis Solhjem do research?
Dmand AI links 3 publications to Dr. Solhjem, published from 2016 to 2022. Dr. Solhjem has worked on 9 clinical trials.
Who does Dr. Matthew Curtis Solhjem publish with?
Dr. Solhjem's most frequent co-authors are Marka Rae Crittenden, MD, PhD (2 shared papers), Kristina Hoot Young, MD, PhD (2 shared papers) and Rehan Saeed Ahmad, MD (1 shared paper).
Selling to radiation oncology practices?
See radiation oncologists in Oregon by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card